MX2016010680A - Perfeccionamiento de expresión de proteína recombinante con el uso de un sistema de retención de célula basado en membrana. - Google Patents
Perfeccionamiento de expresión de proteína recombinante con el uso de un sistema de retención de célula basado en membrana.Info
- Publication number
- MX2016010680A MX2016010680A MX2016010680A MX2016010680A MX2016010680A MX 2016010680 A MX2016010680 A MX 2016010680A MX 2016010680 A MX2016010680 A MX 2016010680A MX 2016010680 A MX2016010680 A MX 2016010680A MX 2016010680 A MX2016010680 A MX 2016010680A
- Authority
- MX
- Mexico
- Prior art keywords
- retention system
- cell
- membrane
- enhancement
- protein expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/28—Constructional details, e.g. recesses, hinges disposable or single use
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/02—Membranes; Filters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/10—Perfusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2511/00—Cells for large scale production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Sustainable Development (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Clinical Laboratory Science (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Peptides Or Proteins (AREA)
Abstract
Se trata del uso innovador de un sistema de retención de célula basado en membrana externa conjuntamente con cultivo celular de perfusión para expresión celular mejorada de proteínas recombinantes, particularmente proteínas de coagulación, tales como rFVIII, rFVIII con Dominio B Eliminado, rFIX o rFVII/rFVIIa. El uso de tal sistema en alta densidad de celula resulta en un cultivo celular más homogéneo debido a las fuerzas mecánicas inducidas durante la operación del sistema de retención, tales como la circulación celular inducida por bombeo a través de las fibras, además que la retención de algunos componentes celulares y de medio permite un ambiente ideal para las células. El uso del método proporcionado resulta en mejoras en productividad celular y en productividad volumétrica. El sistema de retención de célula basado en membrana es descartable y cuando es conectado a un biorreactor descartable, el mismo permite que todo el sistema de perfusión sea descartable cuando el medio y la recolección son desechados en sacos descartables. El sistema biorreactor de perfusión descartable puede ser operado como un sistema cerrado y no requiere limpieza, vaporización o el uso de una instalación con tubería rígida.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461940493P | 2014-02-17 | 2014-02-17 | |
PCT/BR2015/000019 WO2015120527A2 (en) | 2014-02-17 | 2015-02-12 | Enhancement of recombinant protein expression using a membrane-based cell retention system |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016010680A true MX2016010680A (es) | 2017-04-27 |
Family
ID=53800716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016010680A MX2016010680A (es) | 2014-02-17 | 2015-02-12 | Perfeccionamiento de expresión de proteína recombinante con el uso de un sistema de retención de célula basado en membrana. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20170009269A1 (es) |
EP (1) | EP3107934A4 (es) |
JP (1) | JP2017506077A (es) |
KR (1) | KR20160138403A (es) |
CN (1) | CN106414490A (es) |
AU (1) | AU2015218193A1 (es) |
BR (1) | BR112016018797A8 (es) |
CA (1) | CA2939872A1 (es) |
CL (1) | CL2016002068A1 (es) |
MX (1) | MX2016010680A (es) |
WO (1) | WO2015120527A2 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015149143A2 (en) | 2014-04-01 | 2015-10-08 | Advantech Bioscience Farmacêutica Ltda. | Stable factor viii formulations with low sugar-glycine |
AU2015240354A1 (en) | 2014-04-01 | 2016-11-17 | Advantech Bioscience Farmaceutica Ltda. | Stabilization of Factor VIII without calcium as an excipient |
CN111344558A (zh) * | 2017-10-06 | 2020-06-26 | 龙沙有限公司 | 使用拉曼光谱法自动控制细胞培养 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6200560B1 (en) * | 1998-10-20 | 2001-03-13 | Avigen, Inc. | Adeno-associated virus vectors for expression of factor VIII by target cells |
US20040229335A1 (en) * | 2003-05-15 | 2004-11-18 | Introgen Therapeutics, Inc. | Methods and compositions for the production of adenoviral vectors |
AU2005229359C1 (en) * | 2004-03-05 | 2011-07-28 | Patheon Holdings I B.V. | Process for cell culturing by continuous perfusion and alternating tangential flow |
WO2009018307A2 (en) * | 2007-07-31 | 2009-02-05 | Wyeth | Analysis of polypeptide production |
RS56484B1 (sr) * | 2009-11-17 | 2018-01-31 | Squibb & Sons Llc | Metode za poboljšanu proizvodnju proteina |
US8668886B2 (en) * | 2011-04-24 | 2014-03-11 | Therapeutic Proteins International, LLC | Separative bioreactor |
AU2015234611A1 (en) * | 2014-03-23 | 2016-11-10 | Advantech Bioscience Farmaceutica Ltda. | Enhancement of recombinant protein expression with copper |
-
2015
- 2015-02-12 MX MX2016010680A patent/MX2016010680A/es unknown
- 2015-02-12 EP EP15748442.9A patent/EP3107934A4/en not_active Withdrawn
- 2015-02-12 BR BR112016018797A patent/BR112016018797A8/pt not_active Application Discontinuation
- 2015-02-12 WO PCT/BR2015/000019 patent/WO2015120527A2/en active Application Filing
- 2015-02-12 KR KR1020167025573A patent/KR20160138403A/ko not_active Application Discontinuation
- 2015-02-12 JP JP2016553414A patent/JP2017506077A/ja not_active Withdrawn
- 2015-02-12 CA CA2939872A patent/CA2939872A1/en not_active Abandoned
- 2015-02-12 CN CN201580019901.8A patent/CN106414490A/zh active Pending
- 2015-02-12 AU AU2015218193A patent/AU2015218193A1/en not_active Abandoned
- 2015-02-12 US US15/119,202 patent/US20170009269A1/en not_active Abandoned
-
2016
- 2016-08-17 CL CL2016002068A patent/CL2016002068A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2939872A1 (en) | 2015-08-20 |
KR20160138403A (ko) | 2016-12-05 |
CL2016002068A1 (es) | 2017-08-04 |
WO2015120527A2 (en) | 2015-08-20 |
EP3107934A4 (en) | 2017-10-18 |
WO2015120527A3 (en) | 2015-12-10 |
CN106414490A (zh) | 2017-02-15 |
BR112016018797A2 (pt) | 2017-08-08 |
US20170009269A1 (en) | 2017-01-12 |
AU2015218193A1 (en) | 2016-10-06 |
EP3107934A2 (en) | 2016-12-28 |
JP2017506077A (ja) | 2017-03-02 |
BR112016018797A8 (pt) | 2020-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201691669A1 (ru) | Связывающие сывороточный альбумин домены фибронектина iii типа | |
CY1121217T1 (el) | Μεθοδοι για συγκομιδη καλλιεργειων κυτταρου θηλαστικων | |
EA202190827A1 (ru) | Вирусные векторы, кодирующие рекомбинантные варианты fviii с повышенной экспрессией для генной терапии гемофилии a | |
SA520412637B1 (ar) | B7 الفيروس الغدي الحال للورم المشفِّر لبروتين | |
CR20170139A (es) | Proteínas de fusión, bacterias recombinantes y métodos de uso de las bacterias recombinantes | |
EA201891142A1 (ru) | Контроль клеточных окислительно-восстановительных уровней | |
EA201491388A1 (ru) | Рекомбинантные белки фактора viii | |
TR201909037T4 (tr) | Yeni protein deamidaz. | |
EA201692025A1 (ru) | Доставка белков, осуществляемая на основе бактерий | |
ES2721309T3 (es) | Composición para preparar tagatosa y método para preparar tagatosa a partir de fructosa | |
ES2722773T3 (es) | Polipéptidos de fHbp meningocócicos modificados | |
ES2694667T3 (es) | Método para producir oxalato oxidasas que tienen actividad óptica cerca de pH fisiológico y uso de tales oxalato oxidasas recombinantes en el tratamiento de enfermedades relacionadas con oxalato | |
BR112017017886A2 (pt) | gerando populações de células endoteliais arteriais | |
CL2016001900A1 (es) | Sobreexpresión de los reguladores de caminos de n-glicosilación para regular la glicosilación de proteinas recombinante | |
EA202092049A1 (ru) | Вирусные векторы, кодирующие рекомбинантные варианты fviii с повышенной экспрессией для генной терапии гемофилии a | |
MX2016010680A (es) | Perfeccionamiento de expresión de proteína recombinante con el uso de un sistema de retención de célula basado en membrana. | |
PH12016500708A1 (en) | Recombinant glycoproteins and uses thereof | |
MX2020003626A (es) | Expresión recombinante de la proteína orf2 de pcv2b en células de insecto. | |
MX2016007224A (es) | Vacuna contra el circovirus porcino tipo 2. | |
MX2016012428A (es) | Aumento de la expresion de proteina recombinante con cobre. | |
RU2013146452A (ru) | Инъекционный или инфузионный раствор триазавирина для лечения вирусных инфекций | |
SG10201803999UA (en) | Recombinant factor viii formulations | |
UA118653C2 (uk) | Суперагоністи глікопротеїнового гормону тривалої дії | |
PH12015502037B1 (en) | Activating adiponectin by casein hydrolysate | |
EA201591832A1 (ru) | Коэкспрессия фактора viii и фактора фон виллебранда |